Long-term clinical results of early-stage lung cancer patients treated with risk-adapted stereotactic body radiotherapy using LINAC or CyberKnife
Clinical results after SBRT at a national comprehensive cancer center demonstrate high LC and LPFS rates and favorable PFS and OS, comparable to published studies. Application of a BED<sub>10</sub> of 132 Gy or higher shows a potential benefit in terms of LPFS and may thus be recommended in the absence of conflict with organ at risk constraints. SBRT with either LINAC or CK is proven to be a well-tolerated but still highly effective treatment for the elderly, medically inoperable early-stage lung cancer population.
Authors
- Csaba Polgár (ORCID: https://orcid.org/0000-0001-7245-0762)
- Mercédesz Gerdán
- Zsolt Levente Jánváry (ORCID: https://orcid.org/0000-0002-4583-4901)
- József Lövey (ORCID: https://orcid.org/0000-0001-6467-191X)
- Katalin Ladányi
- Gábor Stelczer
- Zsuzsa S. Kocsis (ORCID: https://orcid.org/0000-0002-4336-3325)
- Tibor Major (ORCID: https://orcid.org/0000-0002-4672-6910)
- Tamás Pócza (ORCID: https://orcid.org/0000-0003-0898-8861)
- Éva Pap
- András Bajcsay
- Gábor Kontra
Institutions
- Semmelweis University (HU)
- Oslo University Hospital (NO)
- Budapest University of Technology and Economics (HU)
- National Institute of Oncology (HU)
Publication Details
- Journal
- Strahlentherapie und Onkologie
- Published
- 2025-08-25
- DOI
- https://doi.org/10.1007/s00066-025-02455-3
- Citations
- 2
- Primary Topic
- Advanced Radiotherapy Techniques
- Type
- article
- Field-Weighted Citation Impact
- 3.77